Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,702,111
+$148,566 QoQ
Shares Held
13,246
+2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,710
of 3,778 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Blueprint, LLC holds $25,782,970 across 8 Drug Manufacturers - General names. MRK ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,696 | $16,427,394 | |
| 2 | JNJ |
Johnson & Johnson
|
12,796 | $3,249,800 | |
| 3 | ABBV |
AbbVie Inc.
|
9,738 | $2,450,470 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
13,246 | $1,702,111 | |
| 5 | PFE |
Pfizer Inc
|
30,778 | $741,134 | |
| 6 | AMGN |
Amgen Inc
|
1,477 | $534,851 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,819 | $356,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,572 | $321,058 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,702,111 | 13,246 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,553,545 | 12,915 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,225,647 | 11,644 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $736,485 | 8,775 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $670,722 | 8,473 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $859,990 | 9,581 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,757,658 | 37,773 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $5,897,511 | 51,933 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,953,913 | 48,093 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,382,025 | 48,367 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,588,147 | 51,258 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,787,072 | 46,499 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,992,117 | 43,263 | Shares | Sole | 2023-10-18 | |
| 2023-03-31 | $3,713,223 | 34,902 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,735,797 | 33,671 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $3,026,601 | 35,144 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $629,528 | 6,905 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $476,710 | 5,810 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $440,066 | 5,742 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $220,222 | 2,932 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $125,054 | 1,608 | Shares | Sole | 2021-08-12 | |
| 2020-09-30 | $1,983,418 | 23,911 | Shares | Sole | 2020-10-27 | |
| No filing history on record for this holder in this stock. | ||||||